Searchable abstracts of presentations at key conferences in endocrinology

ea0084ps1-01-07 | COVID & Thyroid Disease | ETA2022

The course and outcome of subacute thyroiditis: A retrospective analysis and predictive model

de Filette Jeroen , de rop jonas , barbe kurt , bravenboer bert

Background: Subacute thyroiditis (SAT) is a destructive thyroiditis which is presumably caused by a viral infections or post-viral inflammatory response. Thyroid dysfunction evolves through a set of stages (hyperthyroidism - hypothyroidism - euthyroidism) and is usually temporary, although some patients may develop permanent hypothyroidism. The risk factors for permanent hypothyroidism remain unclear.Methods: A retrospective analysis of patients with SAT...

ea0088022 | Abstracts | BES2022

Rapid growing thyroid nodule: the good one in the bad clothes

Marchi Lucrezia De , Filette Jeroen de , Johan Verhelst

Background: Primary thyroid lymphoma (PTL) is a rare thyroid tumor that accounts for only 5% of thyroid malignancies, but is associated with higher mortality than differentiated thyroid cancer. The major risk factor for thyroid lymphoma is the presence of Hashimoto’s thyroiditis (HT) with an estimated 60-fold increased risk. The lymphocytic infiltrate in HT appears to develop into lymphoma in a minority of patients. The differential diagnosis between Hashimoto’s thyr...

ea0057012 | Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review of the literature | BES2018

Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review of the literature

de Filette Jeroen MK , Joeri Pen , Brigitte Velkeniers , Kharagjitsingh Aan V

Introduction: Immune checkpoint inhibitors have revolutionized the treatment of advanced malignancies. These monoclonal antibodies target cytotoxic T-lymphocyte antigen-4 (CTLA-4), programmed cell death 1 (PD-1) or its ligand (PD-L1). Endocrine side effects are common, and while hypophysitis and thyroid disorders are predominant, checkpoint-blockade associated diabetes mellitus deserves further notice.Methods: We present the case of a 61-year old male wi...

ea0056gp211 | Pituitary Clinical | ECE2018

A systematic review and meta-analysis of endocrine-related adverse events associated with immune checkpoint inhibitors

de Filette Jeroen , Andreescu Corina , Cools Filip , Bravenboer Bert , Velkeniers Brigitte

Background: Monoclonal antibodies targeting CTLA-4 and PD-1/PD-L1 are promising for a wide range of advanced malignacies. These immune checkpoint inhibitors (ICI) provoke endocrine adverse events including hypopituitarism and primary thyroid disease.Methods: PubMed was searched through August 22nd, 2017, for relevant articles on endocrinopathies and ICI, by two reviewers independently (J.d.F. and C.A.). The weighted incidence and odds-ratio were estimate...